EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Colonoscopic and oral microbiota transplant therapy yield similar stool and neoterminal ileal engraftment profiles in a single-blind pilot randomized trial

Daphne Moutsoglou iD, Christopher Staley iD, Amanda J Kabage, Alexander Khoruts iD, Byron P Vaughn iD

Inflammatory Bowel Diseases · 01.08.2026 · 32 (8) · 1576-1586

DOI: 10.1093/ibd/izag096 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Inflammatory Bowel Diseases, online erschienen am 23.06.2026. Verfasst von Daphne Moutsoglou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology Section, Minneapolis VA Health Care System, Minneapolis, MN 55417, United States. Hauptthemen laut MEDLINE: Colonoscopy, Ileum, Fecal Microbiota Transplantation, Feces. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, Achieving Cures Together (a nonprofit), Crohn's and Colitis Litwin Pioneer Award.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The intestinal microbiota play a key role in Crohn’s disease (CD) and postoperative recurrence following ileocecal resection. Microbiota transplant therapy (MTT) could impact postoperative CD recurrence. This study aimed to compare donor engraftment kinetics in the stool and neoterminal ileum in CD participants with a history of ileocecal resection given either liquid MTT administered via colonoscopy or encapsulated, lyophilized, oral MTT.

Methods

We performed a single-blind (participant), pilot, randomized trial evaluating ileal and stool engraftment kinetics in participants given MTT either via colonoscopy or oral capsules. Participants with a history of ileocecal resection underwent baseline colonoscopy and were randomized (1:1) to a single administration of liquid MTT at the time of colonoscopy or 5 days of MTT capsules. All underwent ileocolonoscopy with biopsies at week 8. Clinical assessments were obtained over 16 weeks.

Results

Alpha and beta diversity were significantly different between baseline neoterminal ileum and stool samples. Stool and mucosal-adherent ileal engraftment levels were not significantly different from each other based on the delivery method at week 8, and stool and ileal engraftments were significantly correlated to each other. Following MTT, there was a significant reduction in CD symptoms measured by the Harvey-Bradshaw Index; however, no differences were noted by the MTT administration route. Donor engraftment did not correlate to clinical outcomes.

Conclusions

In this pilot study of MTT in postoperative CD, oral and colonoscopy administration had similar donor engraftment. Oral MTT was well tolerated, supporting further evaluation of oral administration earlier in the postoperative disease course. NCT05248191, FMT for Postop Crohn’s Disease, https://clinicaltrials.gov/study/NCT05248191

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ColonoscopyIleumFecal Microbiota TransplantationFecesCrohn DiseaseHumansPilot ProjectsSingle-Blind MethodMaleFemaleAdultMiddle AgedAdministration, OralYoung AdultFollow-Up Studies

Stichwörter der Autor:innen

donor similarityfecal microbiota transplantinflammatory bowel disease

Autor:innen und Institutionen

  • Gastroenterology Section, Minneapolis VA Health Care System, Minneapolis, MN 55417, United States.
  • Department of Medicine, University of Minnesota, Minneapolis, MN 55455, United States.
  • Division of Basic and Translational Research, Department of Surgery, University of Minnesota, Minneapolis, MN 55455, United States.
  • Division of Gastroenterology, Hepatology, and Nutrition, University of Minnesota, Minneapolis, MN 55455, United States.

ORCID-Profile: Daphne Moutsoglou, Christopher Staley, Alexander Khoruts, Byron P Vaughn

Förderung

  • NIH HHS
  • Achieving Cures Together (a nonprofit)
  • Crohn's and Colitis Litwin Pioneer Award
  • National Institutes of Health
  • Crohn’s and Colitis Litwin Pioneer Award

Zitieren

APA

Moutsoglou, D., Staley, C., Kabage, A. J., Khoruts, A., & Vaughn, B. P. (2026). Colonoscopic and oral microbiota transplant therapy yield similar stool and neoterminal ileal engraftment profiles in a single-blind pilot randomized trial. Inflammatory Bowel Diseases, 32(8), 1576-1586. https://doi.org/10.1093/ibd/izag096

Vancouver

Moutsoglou D, Staley C, Kabage AJ, Khoruts A, Vaughn BP. Colonoscopic and oral microbiota transplant therapy yield similar stool and neoterminal ileal engraftment profiles in a single-blind pilot randomized trial. Inflammatory Bowel Diseases. 2026;32(8):1576-1586. doi:10.1093/ibd/izag096

BibTeX
@article{Moutsoglou2026,
  author = {Moutsoglou, Daphne and Staley, Christopher and Kabage, Amanda J and Khoruts, Alexander and Vaughn, Byron P},
  title = {Colonoscopic and oral microbiota transplant therapy yield similar stool and neoterminal ileal engraftment profiles in a single-blind pilot randomized trial},
  journal = {Inflammatory Bowel Diseases},
  year = {2026},
  volume = {32},
  number = {8},
  pages = {1576--1586},
  doi = {10.1093/ibd/izag096}
}
Kostenlos starten →